longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

DUALITYBIO-B

09606

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Q2 FY2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: DUALITYBIO-B(09606) the Revenue is 126.57 M (-81.18%);the EBIT is -528.34 M (-931%);the EPS is -5.87 (+78.44%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.13B81.18%
----
----
EBIT
-0.53B930.98%
----
----
EPS
-5.867178.44%
----
----

Revenue

ActualEstimateUnit: HKD
qf

EBIT

ActualEstimateUnit: HKD
qf

Net income

ActualEstimateUnit: HKD
qf

EPS

ActualEstimateUnit: HKD
qf